VIRUS INACTIVATION OF FRESH-FROZEN PLASMA BY A SOLVENT DETERGENT PROCEDURE - BIOLOGICAL RESULTS

被引:49
作者
PIQUET, Y
JANVIER, G
SELOSSE, P
DOUTREMEPUICH, C
JOUNEAU, J
NICOLLE, G
PLATEL, D
VEZON, G
机构
[1] OCTAPHARMA AG,GLARUS,SWITZERLAND
[2] CHU PELLEGRIN,BORDEAUX,FRANCE
[3] FAC PHARM BORDEAUX,BORDEAUX,FRANCE
关键词
D O I
10.1111/j.1423-0410.1992.tb01230.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to increase the safety of blood products, we have developed a procedure for the virus inactivation of fresh frozen plasma. Several batches have been prepared and with the first 10 batches, each of them composed of 60 litres of plasma, we have determined a set of biological parameters. Virus inactivation was realised using TnBP (1%) and Octoxynol 9 (1%). After their elimination with castor oil using chromatography on insolubilized C18 resin, glycine was added and the pH of the plasma was adjusted to 7.4. Plastic bags were aseptically filled with a mean volume of 200 ml of plasma. The mean levels of coagulation factors were all over 0.7 U/ml and their recovery from initial plasma was nearly the same as total protein except for factor VIII:C. The net loss in factor VIII:C was 16%, when including the dilution of plasma. In vivo and in vitro tests demonstrated that in the final product there were no activated factors. As in fresh frozen plasma, the protein concentration was over 50 g/l and the potassium level lower than 5 mmol/l. According to these results, virus-inactivated plasma has the same qualities of fresh frozen plasma and could now replace it.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 28 条
[1]  
AMIRAL J, 1984, CLIN CHEM, V30, P1512
[2]   FACTOR-VIII-RELATED ANTIGEN - MEASUREMENT BY ENZYME IMMUNOASSAY [J].
BARTLETT, A ;
DORMANDY, KM ;
HAWKEY, CM ;
STABLEFORTH, P ;
VOLLER, A .
BRITISH MEDICAL JOURNAL, 1976, 1 (6016) :994-996
[3]   THE ASSAY OF ANTIHAEMOPHILIC-GLOBULIN ACTIVITY [J].
BIGGS, R ;
EVELING, J ;
RICHARDS, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1955, 1 (01) :20-34
[4]  
CAMBRECHT B, 1991, VOX SANG, V60, P207
[5]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[6]  
DOUTREMEPUICH C, 1983, HAEMOSTASIS, V13, P109
[7]  
ELSON EC, 1978, AM J CLIN PATHOL, V69, P354
[8]   CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION .36. INACTIVATION OF THE VIRUS OF HOMOLOGOUS SERUM HEPATITIS IN SOLUTIONS OF NORMAL HUMAN SERUM ALBUMIN BY MEANS OF HEAT [J].
GELLIS, SS ;
NEEFE, JR ;
STOKES, J ;
STRONG, LE ;
JANEWAY, CA ;
SCATCHARD, G .
JOURNAL OF CLINICAL INVESTIGATION, 1948, 27 (02) :239-244
[9]  
GORNALL AG, 1949, J BIOL CHEM, V177, P751
[10]   CLINICAL-EVALUATION OF THE HEPATITIS SAFETY OF A BETA-PROPIOLACTONE ULTRAVIOLET TREATED FACTOR-IX CONCENTRATE (PPSB) [J].
HEINRICH, D ;
KOTITSCHKE, R ;
BERTHOLD, H .
THROMBOSIS RESEARCH, 1982, 28 (01) :75-83